Chainlink vs Enzyme — how do they compare? Chainlink trades at Rp157,523 (market cap Rp117,46T, Rp3,85T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Chainlink is far larger — about 875717.6× Enzyme's market cap, and Chainlink's supply is capped (748,1M / 1B LINK (75%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Chainlink for 62 Days and Enzyme for 29 Days on average.
| LINK | MLN | |
|---|---|---|
Market Cap | Rp117,46T | Rp134,13M |
Volume (24h) | Rp3,85T | Rp104,56M |
Circulating Supply | 748,1M / 1B LINK (75%) | 3,3M MLN |
Typical Hold Time | 62 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Chainlink (LINK) is trading at Rp157,523, with a market cap of Rp117.46 trillion, showing a bullish technical signal driven by strong moving averages. The token is near resistance at Rp157,143, with RSI_6 indicating overbought conditions. Recent news highlights positive regulatory developments, including a former Chainlink executive joining the SEC Crypto Task Force, potentially boosting institutional confidence. The circulating supply is 748.1 million LINK (75% of max), with an average hold time of 62 days, suggesting moderate investor retention.
Overall outlook is cautiously optimistic due to bullish technicals and regulatory tailwinds, but risks include overbought signals and crypto market volatility. Key opportunities lie in Chainlink's role as a blockchain oracle leader, while major risks involve regulatory uncertainty and price corrections from current levels.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Founded in 2017 by Sergey Nazarov , Chainlink is a blockchain abstraction layer that enables universally connected smart contracts. Through a decentralized oracle network, Chainlink allows blockchains to securely interact with external data feeds, events and payment methods, providing the critical off-chain information needed by complex smart contracts to become the dominant form of digital agreement.
Read more on LINK →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →